Quantcast
Home > Quotes > GRFS

Grifols, S.A. American Depositary Shares (GRFS) Quote & Summary Data

GRFS 
$20.8
*  
0.11
0.53%
Get GRFS Alerts
*Delayed - data as of Nov. 21, 2018 10:49 ET  -  Find a broker to begin trading GRFS now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    GRFS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 20.80 / $ 20.81
1 Year Target
23
Today's High / Low
$ 20.96 / $ 20.80
Share Volume
43,875
50 Day Avg. Daily Volume
1,490,454
Previous Close
$ 20.69
52 Week High / Low
$ 25.18 / $ 17.47
Market Cap
14,221,745,470
P/E Ratio
16.91
Forward P/E (1y)
17.68
Earnings Per Share (EPS)
$ 1.23
Annualized Dividend
$ .35
Ex Dividend Date
11/30/2018
Dividend Payment Date
12/11/2018
Current Yield
1.79 %
Beta
1.15

Special Dividend Data

Special Dividend
$ 0.0136
Special Dividend Date
Jun. 5, 2014
Special Dividend Payment Date
N/A

Intraday Chart

Shares Traded

Share Volume:
43,875
50 Day Avg. Daily Volume:
1,490,454

P/E Ratio

P/E Ratio:
16.91
Forward P/E (1y):
17.68
Earnings Per Share (EPS):
$ 1.23

Trading Range

The current last sale of $20.80 is 19.06% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 20.96 $ 25.18
 Low: $ 20.80 $ 17.47

ETFs with GRFS as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
3.88% First Trust Amex Biotech Index Fund (FBT) -8.26 (-5.90%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We were founded in 1940 in Barcelona, Spain by Dr. José Antonio Grifols i Roig, a specialist and pioneer in blood transfusions and clinical analysis and the grandfather of our current Chairman of the Board. We have been making and selling plasma derivative products for more than 70 years. Over the last 25 years, we have grown from a predominantly domestic Spanish company 26 -------------------------------------------------------------------------------- Table of Contents into a global company by expanding both organically and through acquisitions throughout Europe, the United States, Latin America and Asia. We were incorporated in Spain as a limited liability company on June 22, 1987 under the name Grupo Grifols, S.A., and we changed our name to Grifols, S.A. in 2005. We conduct business under the commercial name "Grifols.  ... More ...  


Risk Grade

Where does GRFS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 20.84
Open Date:
Nov. 21, 2018
Close Price:
N/A
Close Date:
N/A

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x